Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Safety and Feasibility of an Integrated Fabric-Type Orthosis for Gait and Balance Improvement in Geriatric Patients

12 novembre 2026 aggiornato da: Seoul National University Hospital

Safety and Feasibility of an Integrated Fabric- Type Orthosis With Muscle-Mimicking and Proprioception-Enhancing Functions for Improving Gait and Balance in Geriatric Patients: Pilot Clinical Trial

This pilot clinical trial aims to evaluate the safety and feasibility of an integrated fabric-type orthosis with muscle-mimicking and proprioception-enhancing functions in older adults with geriatric conditions affecting gait and balance. The wearable orthosis provides lower-limb assistance through a fabric-based actuation system and vibrotactile proprioceptive stimulation. Thirty participants aged 65 years or older will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. Outcome measures include gait performance, postural sway, one-leg standing balance, joint position sense, muscle activation, physiological responses, fatigue, and device-related adverse events. The study is designed as an exploratory pilot trial to assess the clinical applicability, usability, and safety of the wearable assistive device in geriatric patients.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Stimato)

30

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: junghyun kim, prof
  • Numero di telefono: 82+1088632341
  • Email: kiking0@naver.com

Luoghi di studio

    • Jongno
      • Seoul, Jongno, Corea del Sud, 03080
        • Reclutamento
        • Seoul National University Hospital
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

65 anni e precedenti (Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

Eligibility for participation in the study requires that all the following criteria are met:

  1. Age: Participants must be 65 years of age or older.

  2. Comprehension and Compliance: Able to fully understand and comply with the instructions and study procedures.

  3. Mobility-Impacting Conditions: Must have at least one of the following conditions affecting mobility: (1)Sarcopenia:

    • Muscle Strength: Handgrip strength of <28 kg for men and <18 kg for women.
    • Muscle Function: Short Physical Performance Battery (SPPB) score of 8 or less.
    • Muscle Mass: Bioelectrical impedance analysis (BIA) showing muscle mass <7.0 kg/m² for men and <5.7 kg/m² for women. (2)Diabetes:
    • Diagnosed distal symmetric polyneuropathy.
    • Sensory impairments in toes or feet. (3)Knee Osteoarthritis:
    • Kellgren-Lawrence grade ≥2.
    • Persistent pain (≥3 months) with a severity of at least 3 on the Numerical Rating Scale (NRS).

Exclusion Criteria:

Individuals meeting any of the following criteria will be excluded from study participation:

  1. Inability to Consent: Unable to provide informed consent or not willing to participate in the study procedures.

  2. Severe Sensory or Motion Limitations: Including severe visual or vestibular impairments that could increase the risk of falling.

  3. Communication Barriers: Significant hearing, speech, or language problems that would hinder communication with study personnel.

  4. Independent Walking Inability: Cannot walk independently without the aid of a walking device.

  5. Other Significant Diseases or Conditions:

    • Neurological disorders that affect walking ability (e.g., stroke, Parkinson's disease).
    • Orthopedic or musculoskeletal conditions severely affecting lower limb function.
    • Severe cardiovascular conditions including uncontrolled hypertension or heart failure.
    • Respiratory diseases requiring regular oxygen therapy.
    • Active cancer treatment or cancer treatment within the past 3 years (except basal cell carcinoma or localized prostate cancer).
    • Severe psychiatric disorders like schizophrenia or bipolar disorder.
  6. Other Exclusionary Factors:

    • Past severe orthopedic surgeries on lower limbs which might affect gait and mobility.
    • Severe back pain or any other condition affecting mobility not already listed.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Integrated Fabric-Type Orthosis Evaluation

Participants will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. The wearable fabric-type orthosis provides muscle-mimicking lower-limb assistance and proprioception-enhancing vibrotactile stimulation for gait and balance support in older adults.

A wearable fabric-type lower-limb orthosis integrating muscle-mimicking actuation and proprioception-enhancing vibrotactile stimulation. The device is designed to assist knee and ankle movements during gait and balance activities in older adults with gait and balance impairments. Participants will be evaluated under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on.

Altri nomi:
  • Soft Exosuit

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Blood Pressure From Before to After Functional Assessment
Lasso di tempo: Immediately before and after the functional assessment at each study visit

Systolic and Diastolic blood pressure will be measured in millimeters of mercury (mmHg) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions.

Immediately before and after the functional assessment at each study visit
Change in Heart Rate From Before to After Functional Assessment
Lasso di tempo: Immediately before and after the functional assessment at each study visit

Heart rate will be measured in beats per minute (bpm) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions.

Immediately before and after the functional assessment at each study visit
Change in Perceived Exertion From Before to After Functional Assessment
Lasso di tempo: Immediately before and after the functional assessment at each study visit

Perceived exertion will be assessed using the Borg Scale before and after completion of the functional assessment. Higher scores indicate greater perceived exertion.

Immediately before and after the functional assessment at each study visit
Change in Pain Intensity From Before to After Functional Assessment
Lasso di tempo: Immediately before and after the functional assessment at each study visit

Pain intensity will be assessed using the Numeric Rating Scale (NRS) before and after completion of the functional assessment. Scores range from 0 to 10, with higher scores indicating greater pain intensity.

Immediately before and after the functional assessment at each study visit

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
6-Minute Walk Test
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate walking endurance and functional mobility by measuring the maximum walking distance achieved within six minutes.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
10-Meter Walk Test
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess gait speed and short-distance walking performance under different orthosis conditions.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
20-Meter Walk Test
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess walking speed and gait performance over a longer walking distance.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Surface Electromyography
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate lower-limb muscle activation patterns during walking using surface electromyography (sEMG).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Static One-Leg Standing Balance Test
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate static balance ability by measuring the duration participants can maintain single-leg standing.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Postural Sway
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess postural stability during quiet standing using center of pressure (COP)-based balance measurements.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Passive Joint Position Reproduction Test
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate proprioceptive accuracy by measuring passive knee joint position reproduction error.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Active Joint Position Reproduction Test
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate proprioceptive accuracy by measuring active knee joint position reproduction error.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Participant Satisfaction
Lasso di tempo: Immediately post-brace activation (power on)

To assess participant satisfaction, comfort, perceived usability, and overall acceptance of the wearable orthosis.

Immediately post-brace activation (power on)
Gait Speed
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Gait speed measured using the GAITRite system, reported in meters per second (m/s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Cadence
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Cadence measured using the GAITRite system, reported in steps per minute (steps/min).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Step Time
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Step time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Step Length
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Step length measured using the GAITRite system, reported in centimeters (cm).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stride Time
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stride time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stride Length
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stride length measured using the GAITRite system, reported in centimeters (cm).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Single Support Time
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Single support time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Double Support Time
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Double support time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stance Time
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stance time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Swing Time
Lasso di tempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Swing time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Direttore dello studio: hyungik shin, prof, Seoul National University Hospital

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

17 giugno 2026

Completamento primario (Stimato)

31 dicembre 2027

Completamento dello studio (Stimato)

31 dicembre 2027

Date di iscrizione allo studio

Primo inviato

21 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

12 novembre 2026

Primo Inserito (Effettivo)

18 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

12 novembre 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • H-2603-077-1726

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .